AAAAAA

   
Results: 1-2 |
Results: 2
Dual neurokinin NK1/NK2 antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N '-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N '-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl] propionamides
Authors: Gerspacher, M La Vecchia, L Mah, R von Sprecher, A Anderson, GP Subramanian, N Hauser, K Bammerlin, H Kimmel, S Pawelzik, V Ryffel, K Ball, HA
Citation: M. Gerspacher et al., Dual neurokinin NK1/NK2 antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N '-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N '-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl] propionamides, BIOORG MED, 11(23), 2001, pp. 3081-3084
N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: An orally active neurokinin NK1/NK2 antagonist
Authors: Gerspacher, M von Sprecher, A Mah, R Anderson, GP Bertrand, C Subramanian, N Hauser, K Ball, HA
Citation: M. Gerspacher et al., N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: An orally active neurokinin NK1/NK2 antagonist, BIOORG MED, 10(13), 2000, pp. 1467-1470
Risultati: 1-2 |